(19)
(11) EP 4 143 303 A1

(12)

(43) Date of publication:
08.03.2023 Bulletin 2023/10

(21) Application number: 21797771.9

(22) Date of filing: 29.04.2021
(51) International Patent Classification (IPC): 
C12N 5/0797(2010.01)
A61P 25/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/00; C12N 5/0622; C12N 2502/081; C12N 2501/599; C12N 2501/25
(86) International application number:
PCT/US2021/029806
(87) International publication number:
WO 2021/222507 (04.11.2021 Gazette 2021/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.05.2020 US 202063018939 P

(71) Applicant: The Children's Medical Center Corporation
Boston, Massachusetts 02115 (US)

(72) Inventors:
  • HE, Zhigang
    Boston, Massachusetts 02115 (US)
  • WANG, Jing
    Boston, Massachusetts 02115 (US)
  • HE, Xuelian
    Boston, Massachusetts 02115 (US)

(74) Representative: Impact Intellectual Property LLP 
1 Sans Walk
London EC1R 0LT
London EC1R 0LT (GB)

   


(54) COMPOSITIONS AND METHODS OF PROMOTING MYELINATION